Radioembolization Cancer Treatment Market, Global Outlook and Forecast 2022-2028

Code: RW00014789697
Market Monitor Global
Aug-2022
Life Sciences
66 Pages

This report contains market size and forecasts of Radioembolization Cancer Treatment in Global, including the following market information:
Global Radioembolization Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radioembolization Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transarterial Radioembolization (TARE) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radioembolization Cancer Treatment include Terumo Corporation, Merit Medical Systems, Cook Medical, Boston Scientific Corporation, Medtronic, Stryker Corporation, Depuy Synthes (J&J) and BTG International Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Radioembolization Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radioembolization Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)
Global Radioembolization Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Others
Global Radioembolization Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Radioembolization Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radioembolization Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radioembolization Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Terumo Corporation
Merit Medical Systems
Cook Medical
Boston Scientific Corporation
Medtronic
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Radioembolization Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radioembolization Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radioembolization Cancer Treatment Overall Market Size
2.1 Global Radioembolization Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Radioembolization Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radioembolization Cancer Treatment Players in Global Market
3.2 Top Global Radioembolization Cancer Treatment Companies Ranked by Revenue
3.3 Global Radioembolization Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Radioembolization Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radioembolization Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radioembolization Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Radioembolization Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Radioembolization Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Radioembolization Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Transarterial Radioembolization (TARE)
4.1.3 Selective Internal Radiation Therapy (SIRT)
4.2 By Type - Global Radioembolization Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Radioembolization Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Radioembolization Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radioembolization Cancer Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Radioembolization Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Radioembolization Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Radioembolization Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Radioembolization Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Radioembolization Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Radioembolization Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Radioembolization Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radioembolization Cancer Treatment Revenue, 2017-2028
6.3.2 US Radioembolization Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Radioembolization Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Radioembolization Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radioembolization Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.3 France Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Radioembolization Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Radioembolization Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radioembolization Cancer Treatment Revenue, 2017-2028
6.5.2 China Radioembolization Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Radioembolization Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Radioembolization Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Radioembolization Cancer Treatment Market Size, 2017-2028
6.5.6 India Radioembolization Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radioembolization Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Radioembolization Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Radioembolization Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Radioembolization Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Radioembolization Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Radioembolization Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Radioembolization Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Terumo Corporation
7.1.1 Terumo Corporation Corporate Summary
7.1.2 Terumo Corporation Business Overview
7.1.3 Terumo Corporation Radioembolization Cancer Treatment Major Product Offerings
7.1.4 Terumo Corporation Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Terumo Corporation Key News
7.2 Merit Medical Systems
7.2.1 Merit Medical Systems Corporate Summary
7.2.2 Merit Medical Systems Business Overview
7.2.3 Merit Medical Systems Radioembolization Cancer Treatment Major Product Offerings
7.2.4 Merit Medical Systems Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Merit Medical Systems Key News
7.3 Cook Medical
7.3.1 Cook Medical Corporate Summary
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Radioembolization Cancer Treatment Major Product Offerings
7.3.4 Cook Medical Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 Cook Medical Key News
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Corporate Summary
7.4.2 Boston Scientific Corporation Business Overview
7.4.3 Boston Scientific Corporation Radioembolization Cancer Treatment Major Product Offerings
7.4.4 Boston Scientific Corporation Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Boston Scientific Corporation Key News
7.5 Medtronic
7.5.1 Medtronic Corporate Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Radioembolization Cancer Treatment Major Product Offerings
7.5.4 Medtronic Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Medtronic Key News
7.6 Stryker Corporation
7.6.1 Stryker Corporation Corporate Summary
7.6.2 Stryker Corporation Business Overview
7.6.3 Stryker Corporation Radioembolization Cancer Treatment Major Product Offerings
7.6.4 Stryker Corporation Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Stryker Corporation Key News
7.7 Depuy Synthes (J&J)
7.7.1 Depuy Synthes (J&J) Corporate Summary
7.7.2 Depuy Synthes (J&J) Business Overview
7.7.3 Depuy Synthes (J&J) Radioembolization Cancer Treatment Major Product Offerings
7.7.4 Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 Depuy Synthes (J&J) Key News
7.8 BTG International Limited
7.8.1 BTG International Limited Corporate Summary
7.8.2 BTG International Limited Business Overview
7.8.3 BTG International Limited Radioembolization Cancer Treatment Major Product Offerings
7.8.4 BTG International Limited Radioembolization Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 BTG International Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Radioembolization Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Radioembolization Cancer Treatment Market Drivers in Global Market
Table 3. Radioembolization Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Radioembolization Cancer Treatment in Global Market
Table 5. Top Radioembolization Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Radioembolization Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Radioembolization Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Radioembolization Cancer Treatment Product Type
Table 9. List of Global Tier 1 Radioembolization Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radioembolization Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Radioembolization Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Radioembolization Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Radioembolization Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Radioembolization Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Radioembolization Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Radioembolization Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Terumo Corporation Corporate Summary
Table 31. Terumo Corporation Radioembolization Cancer Treatment Product Offerings
Table 32. Terumo Corporation Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merit Medical Systems Corporate Summary
Table 34. Merit Medical Systems Radioembolization Cancer Treatment Product Offerings
Table 35. Merit Medical Systems Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Cook Medical Corporate Summary
Table 37. Cook Medical Radioembolization Cancer Treatment Product Offerings
Table 38. Cook Medical Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Boston Scientific Corporation Corporate Summary
Table 40. Boston Scientific Corporation Radioembolization Cancer Treatment Product Offerings
Table 41. Boston Scientific Corporation Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Medtronic Corporate Summary
Table 43. Medtronic Radioembolization Cancer Treatment Product Offerings
Table 44. Medtronic Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Stryker Corporation Corporate Summary
Table 46. Stryker Corporation Radioembolization Cancer Treatment Product Offerings
Table 47. Stryker Corporation Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Depuy Synthes (J&J) Corporate Summary
Table 49. Depuy Synthes (J&J) Radioembolization Cancer Treatment Product Offerings
Table 50. Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. BTG International Limited Corporate Summary
Table 52. BTG International Limited Radioembolization Cancer Treatment Product Offerings
Table 53. BTG International Limited Radioembolization Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Radioembolization Cancer Treatment Segment by Type in 2021
Figure 2. Radioembolization Cancer Treatment Segment by Application in 2021
Figure 3. Global Radioembolization Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Radioembolization Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Radioembolization Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radioembolization Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Radioembolization Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Radioembolization Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Terumo Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merit Medical Systems Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cook Medical Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boston Scientific Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medtronic Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Stryker Corporation Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Depuy Synthes (J&J) Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BTG International Limited Radioembolization Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE